Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feigenbaum

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Pharmacology, Biochemistry, and Behavior|February 1, 1982
The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypyJ J Feigenbaum, J Yanai, R B Blass, et al.
Peptides|January 1, 1996
Receptor inactivation by dye-neuropeptide conjugates: 2. Characterization of the quantum yield of singlet oxygen generated by irradiation of dye-neuropeptide conjugatesJ J Feigenbaum, M D Choubal, D S Crumrine, et al.
Neurochemical Research|February 1, 1997
On the synthesis of neurotransmitter receptor agonists with antagonist potentialD S Crumrine, M D Choubal, J R Kanofsky, et al.
European Journal of Pharmacology|January 11, 1980
The role of dopaminergic mechanisms in naloxone-induced inhibition of apomorphine-induced stereotyped behaviorB H Moon, J J Feigenbaum, P E Carson, et al.
Clinical Biochemistry|October 1, 1990
The molecular basis of Tay-Sachs disease: mutation identification and diagnosisD J Mahuran, B L Triggs-Raine, A J Feigenbaum, et al.
American Journal of Medical Genetics|April 12, 2001
DHCR7 genotypes of cousins with Smith-Lemli-Opitz syndromeM J Nowaczyk, T Heshka, B Eng, et al.
Psychopharmacology|January 1, 1982
Haloperidol-induced plasma prolactin release: sensitivity, reliability, and comparison to haloperidol antagonism of dopamine agonist-induced stereotyped behavior in the ratJ J Feigenbaum, B H Moon, R Catterton, et al.
Harefuah|March 1, 1979
[The emergency room in a general hospital: a link in the health service system]L M Epstein, J Feigenbaum, A Tamir, et al.
Peptides|January 1, 1996
Receptor inactivation by dye-neuropeptide conjugates: 1. The synthesis of Cys-containing dye-neuropeptide conjugatesJ J Feigenbaum, M D Choubal, K Payza, et al.
Social Science History|December 16, 2024
Racial Inequality in the Prime of Life: Infectious Disease Mortality in U.S. Cities, 1906-1933Aja Antoine-Jones, James J Feigenbaum, Lauren Hoehn-Velasco, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Pharmacology, Biochemistry, and Behavior|February 1, 1982
The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypyJ J Feigenbaum, J Yanai, R B Blass, et al.
Peptides|January 1, 1996
Receptor inactivation by dye-neuropeptide conjugates: 2. Characterization of the quantum yield of singlet oxygen generated by irradiation of dye-neuropeptide conjugatesJ J Feigenbaum, M D Choubal, D S Crumrine, et al.
Neurochemical Research|February 1, 1997
On the synthesis of neurotransmitter receptor agonists with antagonist potentialD S Crumrine, M D Choubal, J R Kanofsky, et al.
European Journal of Pharmacology|January 11, 1980
The role of dopaminergic mechanisms in naloxone-induced inhibition of apomorphine-induced stereotyped behaviorB H Moon, J J Feigenbaum, P E Carson, et al.
Clinical Biochemistry|October 1, 1990
The molecular basis of Tay-Sachs disease: mutation identification and diagnosisD J Mahuran, B L Triggs-Raine, A J Feigenbaum, et al.
American Journal of Medical Genetics|April 12, 2001
DHCR7 genotypes of cousins with Smith-Lemli-Opitz syndromeM J Nowaczyk, T Heshka, B Eng, et al.
Psychopharmacology|January 1, 1982
Haloperidol-induced plasma prolactin release: sensitivity, reliability, and comparison to haloperidol antagonism of dopamine agonist-induced stereotyped behavior in the ratJ J Feigenbaum, B H Moon, R Catterton, et al.
Harefuah|March 1, 1979
[The emergency room in a general hospital: a link in the health service system]L M Epstein, J Feigenbaum, A Tamir, et al.
Peptides|January 1, 1996
Receptor inactivation by dye-neuropeptide conjugates: 1. The synthesis of Cys-containing dye-neuropeptide conjugatesJ J Feigenbaum, M D Choubal, K Payza, et al.
Social Science History|December 16, 2024
Racial Inequality in the Prime of Life: Infectious Disease Mortality in U.S. Cities, 1906-1933Aja Antoine-Jones, James J Feigenbaum, Lauren Hoehn-Velasco, et al.
Pageof 7